Is EXPGY a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Experian plc (EXPGY) rests on US B2B data and decisioning: North America B2B grew 11% organically in the June 2026 quarter, faster than the group, and it is the engine of Experian's earnings. The bear case rests on the most immediate risk is FICO. Analysts covering it publish targets from $42.00 to $44.00 against a $35.48 price, so even the professionals disagree by 5% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Experian plc runs credit bureaus and the data, analytics and software built on top of them. Lenders pay it for credit reports, scores, identity checks, fraud tools and decisioning software, which make up the B2B side (about 73% of revenue as of the June 2026 quarter). The rest is Consumer Services: free and paid memberships that let people check their credit score and file, plus marketplace referral fees when a member takes out a card or loan through the app. Experian had more than 215 million free consumer members at the end of fiscal 2026. Inside B2B, Financial Services (banks, card issuers, mortgage and auto lenders) is about 53% of group revenue, and Verticals (health, automotive, marketing data, insurance and others) about 20%. Geography is heavily weighted to the US. In the June 2026 quarter North America was about 67% of group revenue, Latin America about 15% (mostly Brazil, through Serasa Experian), the UK and Ireland about 11%, and EMEA and Asia Pacific about 7%. For fiscal 2026, the year to 31 March 2026, Experian reported total revenue of ~$8.45 billion, up 12%, with 8% organic growth (9% in the fourth quarter). Benchmark EBIT from ongoing activities rose 15% to ~$2.41 billion, a 28.6% margin, and Benchmark EPS rose 15% to 179.8 US cents. The company traces back to CCN, the credit-data arm of Britain's Great Universal Stores (GUS), which bought the US credit business of TRW in 1996 and named the combined operation Experian. GUS demerged Experian in October 2006, when it listed on the London Stock Exchange, and the US ADR programme dates from the same month. The 2007 purchase of Serasa made it the leading bureau in Brazil. Acquisitions continue at a steady pace: Experian spent ~$792 million on deals in fiscal 2026, bought KYC360 in the UK and closed the purchase of idwall, a Brazilian digital identity specialist, on 1 July 2026. Brian Cassin has been chief executive since 2014 and Lloyd Pitchford is chief financial officer. The company's corporate head office is in Dublin, and it employed about 25,200 people across 33 countries at the end of fiscal 2026. The investment picture is a quality business at a lower price than it has carried for years. Benchmark operating cash flow was ~$2.2 billion in fiscal 2026 (93% conversion), return on capital employed was 17.2%, and net debt was 1.7x Benchmark EBITDA. Management raised the dividend 11% and launched a new $1 billion buyback, after ~$725 million of repurchases in fiscal 2026. Against that, the ADR closed at ~$35.48 on 9 October 2026, near the bottom of a ~$32 to ~$49 52-week range, after FICO moved to license mortgage scores directly to resellers and Q1 fiscal 2027 organic growth slowed to 7%.

The bull case: what would have to be true for $44.00

The most optimistic published target on EXPGY is $44.00, +24.0% from the $35.48 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. US B2B data and decisioning

North America B2B grew 11% organically in the June 2026 quarter, faster than the group, and it is the engine of Experian's earnings. Mortgage was named as a driver of Financial Services growth, while Experian also sells analytics, fraud and identity tools and the Ascend platform to the same lenders. Each extra product sold to an existing bank client carries high incremental margin, because the underlying credit file already exists. Experian's FY27 guidance assumes this side keeps growing even as consumer revenue slows. What to watch in the November half-year report is whether North America B2B stays near double digits once mortgage volumes normalise and the FICO pricing changes flow through.

2. Latin America and Serasa

Latin America is about 15% of group revenue and grew 12% organically in the June 2026 quarter, with reported growth of 25% helped by a stronger Brazilian real. Serasa Experian is the leading credit bureau in Brazil and runs a large consumer business there; Latin America Consumer Services grew 22% organically in the quarter. The idwall acquisition, closed on 1 July 2026, adds digital identity verification to that platform.

3. Consumer Services after the breach contracts

Consumer Services is about 27% of revenue but grew only 2% organically in Q1 fiscal 2027, and North America consumer revenue fell 2%. Experian attributes the decline to the planned wind-down of two long-term mass data breach support contracts, where it provided credit monitoring to people affected by other companies' breaches. In September 2026 Experian said its app had become the first personal finance app integrated with Google Gemini, part of a push to put its credit data inside AI assistants. Growth here should improve once the breach contracts lap, which management has framed as a fiscal 2027 headwind rather than a permanent one.

4. Health, auto and other verticals

Verticals are about 20% of group revenue and grew 7% organically in the June 2026 quarter. Experian Health sells patient access, eligibility and claims management software to US hospitals and health systems, and the company highlighted its Patient Access Curator product as a driver. A September 2026 study it published said the tool prevented more than $50 million of revenue losses for one composite health system. Automotive, led by AutoCheck vehicle history reports, maintained good momentum. Neither depends much on how much credit banks are writing.

5. Capital returns and bolt-on deals

Experian converts most of its profit into cash, which funds a rising dividend, buybacks and a steady flow of bolt-on acquisitions. The FY26 dividend of 69.25 US cents was paid in two parts (21.25 cents in February and 48 cents in July 2026), and the $1 billion buyback runs to 30 June 2027. Leverage of 1.7x net debt to EBITDA leaves room for more deals of the idwall and KYC360 type. With the ADR down roughly 29% over twelve months, the same buyback budget retires more shares than it would have a year earlier.

6. Margin expansion and AI tools

Management guided to margin expansion at the higher end of its medium-term framework for fiscal 2027, after a 50 basis point improvement to 28.6% in fiscal 2026. Its pitch on AI is that proprietary credit and identity data become more valuable when lenders and consumers use AI agents, and it has added integrations with Snowflake, Workday (for income and employment verification) and Google Gemini in 2026. Whether those translate into measurable revenue is something investors will look for in the half-year disclosure.

The bear case: what would have to be true for $42.00

The most pessimistic published target is $42.00, +18.4% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Experian plc is worth if the risks below bite instead of the drivers above.

The most immediate risk is FICO. In late 2025 Fair Isaac launched a programme letting mortgage tri-merge resellers calculate and distribute FICO scores directly, bypassing the three bureaus, and Experian's FY26 results cite FICO mortgage royalties as a headwind to margins; Experian shares fell ~4% in London on the day of the announcement, and Jefferies estimated FICO's new models could hit bureau earnings by 10% to 15% on average. The second is slowing growth: Q1 fiscal 2027 organic growth of 7% was down from 9% in the prior quarter, EMEA and Asia Pacific grew just 1%, and the midpoint of FY27 organic guidance (6% to 8%) came in below what some analysts expected. Consumer Services is shrinking in North America while the breach contracts run off. Credit bureaus are regulated businesses, and the US Consumer Financial Protection Bureau, the UK Financial Conduct Authority and Brazilian regulators can change what data may be held and how consumer products are sold; data security is a standing exposure for a company holding files on hundreds of millions of people. Currency matters too, because Experian reports in dollars but earns a meaningful share in reais, sterling and euros. For ADR holders specifically, EXPGY trades OTC (on the OTCQX tier) with thinner volume than the London line, so spreads can be wider; dividends paid directly by the company are subject to 25% Irish dividend withholding tax unless an exemption applies, so the amount received can be lower than the declared rate depending on how the depositary and the holder's paperwork handle it.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding EXPGY already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on EXPGY

3 analysts cover EXPGY, with an average target of $43.00 (+21.2% against $35.48) and a split of 3 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the EXPGY forecast and price target page.

How is EXPGY valued? (as of October 2026)

Price

$35.48

Market cap

$31.08B

P/E (TTM)

21.77

Forward P/E

15.53

Price / book

5.75

Beta

0.90

52-week range

$32.00 to $49.17

Snapshot for EXPGY as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Revenue (FY26, to March 2026): ~$8.45B (+12%; 8% organic)
Benchmark EBIT (FY26): ~$2.41B (28.6% margin)
Benchmark EPS (FY26): 179.8 US cents (+15%)
Market cap: ~$31.4B (ADR ~$35.48, Oct 9, 2026)
Trailing P/E: ~20x (~18x forward)
Dividend (FY26): 69.25 US cents (~1.9% yield)

At ~$35.48 per ADR, Experian trades at roughly 20 times its fiscal 2026 Benchmark EPS of 179.8 cents, and around 18 times forward estimates. That is a lower multiple than the stock has commanded through most of the last decade, and it reflects the FICO licensing change and the slower Q1 rather than any fall in reported profit: Benchmark EBIT grew 15% last year and statutory pre-tax profit 26% to ~$1.95 billion. Guidance for fiscal 2027 still calls for double-digit Benchmark EPS growth on 8% to 11% total revenue growth. If that holds, the multiple compresses further on forward numbers. The yield is modest because Experian returns more cash through buybacks ($1 billion authorised to June 2027) than through dividends.

How do you decide if EXPGY is a buy?

Rather than asking whether EXPGY is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the bull case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold EXPGY indirectly through an index or sector ETF before adding more.

What would change your mind on EXPGY

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

Bull case breaks if: US B2B data and decisioning stalls in the reported numbers rather than in the narrative around them.
Bear case breaks if: the most immediate risk is FICO fails to materialise over several reporting periods while the drivers keep compounding.
Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the EXPGY stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about EXPGY against your real portfolio and see your actual exposure before deciding.

Investing in Experian plc with AI

Connect the broker you already use and ask Walnut's AI how EXPGY fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

Does EXPGY fit me?

FAQ

Is EXPGY a good stock to buy right now?

That depends on which case you find more convincing, and both are on this page. The bull case rests on US B2B data and decisioning, with revenue (fy26, to march 2026) at ~$8.45B (+12%; 8% organic). The bear case rests on the most immediate risk is FICO. Analysts covering it are spread from $42.00 to $44.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell EXPGY?

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The most immediate risk is FICO. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $42.00, +18.4% from the $35.48 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for EXPGY?

US B2B data and decisioning. North America B2B grew 11% organically in the June 2026 quarter, faster than the group, and it is the engine of Experian's earnings. The most optimistic analyst target on EXPGY is $44.00, +24.0% from the $35.48 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for EXPGY?

What does Experian plc do?

Experian is the world's largest consumer credit bureau, selling credit data, scores, fraud and identity tools to lenders, plus consumer credit apps.

What would have to change for EXPGY to stop being worth holding?

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (US B2B data and decisioning) stalling in the reported numbers rather than in the narrative, the risk above (the most immediate risk is FICO) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What is EXPGY?

EXPGY is the ticker for Experian plc's American Depositary Receipts, which trade over the counter in the US on the OTCQX tier. Each ADR represents one Experian ordinary share, which is listed on the London Stock Exchange as EXPN and is part of the FTSE 100. The programme is a sponsored Level 1 ADR with J.P. Morgan as depositary, so it is not listed on the NYSE or Nasdaq.

How do I buy Experian stock in the US?

Most US brokerages that allow OTC trading let you buy EXPGY like any other ticker, usually in US dollars during US market hours. Some brokers charge extra or restrict OTC securities, so availability varies. Investors with international trading access can also buy EXPN directly in London in pence. One EXPGY ADR equals one EXPN share, so the prices should track each other after adjusting for the dollar-sterling rate.

Does Experian pay a dividend?

Yes. Experian declares dividends in US cents and pays twice a year. For fiscal 2026 the total was 69.25 cents, up 11%, paid as 21.25 cents in February 2026 and 48 cents in July 2026. The ADR went ex-dividend on 26 June 2026 for the larger payment. At ~$35.48 that is a yield of roughly 1.9%.

Walnut is informational, not investment advice, and gives no verdict on EXPGY. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.